SI9011223B - Indenoindolne spojine - Google Patents

Indenoindolne spojine Download PDF

Info

Publication number
SI9011223B
SI9011223B SI9011223A SI9011223A SI9011223B SI 9011223 B SI9011223 B SI 9011223B SI 9011223 A SI9011223 A SI 9011223A SI 9011223 A SI9011223 A SI 9011223A SI 9011223 B SI9011223 B SI 9011223B
Authority
SI
Slovenia
Prior art keywords
tetrahydro
formula
indole
cis
hydrogen
Prior art date
Application number
SI9011223A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9011223A (en
Inventor
Malcolm Sainsbury
Howard G. Shertzer
Original Assignee
University Of Bath
University Of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Bath, University Of Cincinnati filed Critical University Of Bath
Publication of SI9011223A publication Critical patent/SI9011223A/sl
Publication of SI9011223B publication Critical patent/SI9011223B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SI9011223A 1989-06-22 1990-06-22 Indenoindolne spojine SI9011223B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8902274A SE8902274D0 (sv) 1989-06-22 1989-06-22 Indenoidole compounds ii
YU122390A YU122390A (sh) 1989-06-22 1990-06-22 Indenoindolova jedinjenja ii

Publications (2)

Publication Number Publication Date
SI9011223A SI9011223A (en) 1997-10-31
SI9011223B true SI9011223B (sl) 1998-08-31

Family

ID=20376370

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9011223A SI9011223B (sl) 1989-06-22 1990-06-22 Indenoindolne spojine

Country Status (34)

Country Link
EP (1) EP0409410B1 (he)
JP (1) JP3064411B2 (he)
KR (1) KR920702679A (he)
CN (1) CN1033029C (he)
AT (1) ATE135688T1 (he)
BG (1) BG60317B2 (he)
CA (1) CA2060897A1 (he)
DD (1) DD297960A5 (he)
DE (1) DE69025998T2 (he)
DK (1) DK0409410T3 (he)
DZ (1) DZ1428A1 (he)
ES (1) ES2084660T3 (he)
FI (1) FI100800B (he)
GR (1) GR3019779T3 (he)
HR (1) HRP920903B1 (he)
HU (1) HUT59097A (he)
IE (1) IE74682B1 (he)
IL (1) IL94830A (he)
IS (1) IS3590A7 (he)
LT (1) LT3675B (he)
LV (1) LV10253B (he)
MX (1) MX21244A (he)
MY (1) MY107311A (he)
NO (1) NO177932C (he)
NZ (1) NZ234175A (he)
PL (1) PL167761B1 (he)
PT (1) PT94468B (he)
RO (1) RO111573B1 (he)
RU (1) RU2104270C1 (he)
SE (1) SE8902274D0 (he)
SI (1) SI9011223B (he)
WO (1) WO1990015799A1 (he)
YU (1) YU122390A (he)
ZA (1) ZA904827B (he)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67274A (en) * 1990-10-16 1995-03-28 Univ Bath Process for producing of tetrahydroindenoindoles and farmaceutical composition comprising them
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
SE9302431D0 (sv) * 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
AU675141B2 (en) * 1993-07-20 1997-01-23 Adir Et Compagnie (Thia)cycloalkyl(b)indoles, process for preparing them and pharmaceutical compositions containing them
US6288099B1 (en) 1998-12-04 2001-09-11 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
EP1135393A2 (en) * 1998-12-04 2001-09-26 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2007009120A2 (en) 2005-07-14 2007-01-18 Irm Llc Heterotetracyclic compounds as tpo mimetics
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
MX363405B (es) * 2011-06-16 2019-03-22 Katholieke Univ Leuven K U Leuven R&D Derivados de indanona, sales farmaceuticamente aceptables o isomeros opticos de los mismos, metodo de preparacion de los mismos, y composiciones farmaceuticas que contienen los mismos como ingrediente activo para prevención o tratamiento de enfermedades virales.
EP3882244A1 (en) 2012-12-14 2021-09-22 Korea Research Institute of Chemical Technology Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient
CA3176727A1 (en) 2020-04-20 2021-10-28 Novartis Ag Antiviral 1,3-di-oxo-indene compounds

Also Published As

Publication number Publication date
KR920702679A (ko) 1992-10-06
SE8902274D0 (sv) 1989-06-22
WO1990015799A1 (en) 1990-12-27
DD297960A5 (de) 1992-01-30
IL94830A0 (en) 1991-04-15
PL285752A1 (en) 1991-03-11
LT3675B (en) 1996-01-25
AU644084B2 (en) 1993-12-02
LV10253B (en) 1995-04-20
RO111573B1 (ro) 1996-11-29
SI9011223A (en) 1997-10-31
NO177932C (no) 1995-12-20
NZ234175A (en) 1992-12-23
HU904825D0 (en) 1992-03-30
CA2060897A1 (en) 1990-12-23
ES2084660T3 (es) 1996-05-16
DE69025998D1 (de) 1996-04-25
IE74682B1 (en) 1997-07-30
IS3590A7 (is) 1990-12-23
IE902247A1 (en) 1991-01-16
PT94468B (pt) 1997-12-31
JPH04505923A (ja) 1992-10-15
ATE135688T1 (de) 1996-04-15
EP0409410A1 (en) 1991-01-23
IE902247L (en) 1990-12-22
DE69025998T2 (de) 1996-08-08
MX21244A (es) 1994-03-31
FI100800B (fi) 1998-02-27
AU5836990A (en) 1991-01-08
ZA904827B (en) 1991-04-24
PT94468A (pt) 1991-02-08
IL94830A (he) 1996-07-23
CN1033029C (zh) 1996-10-16
NO177932B (no) 1995-09-11
LV10253A (lv) 1994-10-20
EP0409410B1 (en) 1996-03-20
FI915999A0 (fi) 1991-12-19
LTIP912A (en) 1995-03-27
RU2104270C1 (ru) 1998-02-10
DZ1428A1 (fr) 2004-09-13
PL167761B1 (pl) 1995-10-31
DK0409410T3 (da) 1996-04-29
NO915049D0 (no) 1991-12-20
HRP920903B1 (en) 1998-06-30
YU122390A (sh) 1992-09-07
CN1051554A (zh) 1991-05-22
GR3019779T3 (en) 1996-07-31
HUT59097A (en) 1992-04-28
NO915049L (no) 1992-02-21
JP3064411B2 (ja) 2000-07-12
HRP920903A2 (hr) 1994-04-30
MY107311A (en) 1995-11-30
BG60317B2 (bg) 1994-07-25

Similar Documents

Publication Publication Date Title
SI9011223B (sl) Indenoindolne spojine
FI102371B (fi) Menetelmä indol-3-yyli-amino-guanidiiniyhdisteiden valmistamiseksi
JP2019517487A (ja) Ｐｔｐｎ１１の複素環式阻害剤
YU30702A (sh) Novi derivati benzoimidazola, korisni agensi protiv proliferacije
CA2413424A1 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
TNSN99161A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
YU97292A (sh) N-fenilalanil i n-fenilglicil derivati dipeptida l-azetidin-2-karboksilne kiseline
CA2358998A1 (en) Substituted bicyclic derivatives useful as anticancer agents
IE892293L (en) Pyrrolidinyl-3-quinolone and naphthyridone- carboxylic acid¹derivatives
SI9400091A (en) Substituted pyrrolo(2,3-b)pyridine derivatives
ATE172731T1 (de) Pyrazolopyridinverbindung und verfahren zu ihrer herstellung
BRPI0911577B1 (pt) Derivados espiro-indol, seus usos no tratamento de doençasparasíticas, e composição farmacêutica
RU94020400A (ru) Производные индола, способ их получения, фармацевтическая композиция, способ лечения головной боли
NL300053I2 (nl) Indoolderivaten voor een behandeling van migraine.
AR031198A1 (es) Procedimiento para la preparacion de derivados de ciclopenta(b)diazepino(6,7,1)indol
ES2701730T3 (es) Proceso para la preparación de (-)-Huperzina A
RU97108048A (ru) Диазепиноиндолы - ингибиторы фосфодиэстераз-iv
TNSN02096A1 (en) Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
IT9048086A1 (it) Composizioni farmaceutiche comprendenti 3-ammino-e-caprolattami per il potenziamento dei processi di apprendimento e della memoria.
WO2019025426A1 (en) COMPOUNDS FOR TREATING INFECTIONS
WO1993007871A1 (en) Methods for the treatment of hyperlipidemia using azaspiranes
KR960701885A (ko) 피리도[1,2,3-데]퀴녹살린 유도체, 그의 제조 방법 및 그의 약제로서의 용도(Pyrido[1,2,3-de]quinoxaline Derivatives, Process for Preparing the Same and their Use in Medicaments)
GB2047683A (en) Pyrido[3,4-e]-as-triazines
RU2008140601A (ru) ЗАМЕЩЕННЫЕ 2-АЛКИЛАМИНО-3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
IT9048605A1 (it) Derivati della 1, 2, 3, 4, -tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.